Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Nathan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|July 28, 2006
Involvement of the RNAse L gene in prostate cancerNelly Kieffer, Martine Schmitz, René Scheiden, et al.
Langenbeck'S Archives of Surgery|August 10, 2011
Lean processes for optimizing OR capacity utilization: prospective analysis before and after implementation of value stream mapping (VSM)Patric Schwarz, Klaus Dieter Pannes, Michel Nathan, et al.
International Journal of Oncology|May 5, 2005
ILK as a potential marker gene to ascertain specific adenocarcinoma cell mRNA isolation from frozen prostate biopsy tissue sectionsNelly Kieffer, Martine Schmitz, Sébastien Plançon, et al.
International Journal of Cancer|December 14, 2006
Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasisMartine Schmitz, Gérard Grignard, Christiane Margue, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|July 28, 2006
Involvement of the RNAse L gene in prostate cancerNelly Kieffer, Martine Schmitz, René Scheiden, et al.
Langenbeck'S Archives of Surgery|August 10, 2011
Lean processes for optimizing OR capacity utilization: prospective analysis before and after implementation of value stream mapping (VSM)Patric Schwarz, Klaus Dieter Pannes, Michel Nathan, et al.
International Journal of Oncology|May 5, 2005
ILK as a potential marker gene to ascertain specific adenocarcinoma cell mRNA isolation from frozen prostate biopsy tissue sectionsNelly Kieffer, Martine Schmitz, Sébastien Plançon, et al.
International Journal of Cancer|December 14, 2006
Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasisMartine Schmitz, Gérard Grignard, Christiane Margue, et al.
Pageof 1